Skip to content
  • CAT
  • ESP
  • ENG
  • About us
  • Contact
El·lipse
  • instagram
  • twitter
  • flickr
  • linkdin
  • facebook
  • youtube
  • Research
  • Public engagement
  • Scientific life
  • Community
  • About us
  • Contact
  • instagram
  • twitter
  • flickr
  • linkdin
  • facebook
  • youtube
  • CAT
  • ESP
  • ENG

Hospital del Mar Research Institute

How to find your data in 5 years workshop
30.01.2016

Fostering honest science with a data management campaign

Grupo de Pilar Navarro (IMIM)
05.10.2015

A basic research group with a translational vision

All the directors of the PRBB centres signed the new edition of the Code of Good Scientific Practice
17.10.2014

Signing of the new PRBB Code of Good Scientific Practice

MARBiobanc stores the biological samples that volunteers donate for research.
29.05.2013

What is a biobank?

Anna Bigas research group (IMIM)
30.03.2012

Anna Bigas: Stem cells and cancer research group

Ferran Sanz is the director of the Research Programme on Biomedical Informatics (GRIB).
18.10.2011

Ferran Sanz: “Habitual competitors are now working together to get better toxicity predictions”

Manuel Pastor, group leader of the PharmacoInformatics group at the GRIB.
15.03.2011

Manuel Pastor: “I owe my scientific vocation to Spiderman”

The brain: the right hemisphere records visual and spatial memories, such as drawings, while the left hemisphere registers verbal memory, for example wors or numbers. Image from Pixabay.
16.03.2010

Studying memory

Cardiovascular diseases are the leading cause of death in industrialized countries. Photo by Alexandru Acea on Unsplash.
26.02.2010

The cardiovascular system

Margarita Puig research group (IMIM)
10.09.2009

“It is dificult to introduce new effective analgesics”

Ferran Sanz is the director of the IMIM-UPF Research Programme on Biomedical Informatics (GRIB).
18.09.2008

Ferran Sanz: “There should be no administrative frontiers on top of knowledge communities”

Drug development is a long and costly process. The clinical assays are the last part. Photo by freestocks.org on Unsplash
14.04.2008

Clinical trials: the long path to the development of new drugs

El·lipse is published by the PRBB Communications and Corporate Relations Area.

Dr Aiguader, 88, 08003 Barcelona, Spain

For any suggestions or collaborations please contact us at ellipse@prbb.org

  • Read past print editions
  • About El·lipse
  • About the PRBB
  • Legal disclaimer
  • instagram
  • twitter
  • flickr
  • linkdin
  • facebook
  • youtube
© 2025 El·lipse, PRBB
  • Home
  • News
  • Our picks
This website uses cookies that provide us with personal information, such as data associated with your browsing. If you click on I AGREE, both we and our Partners can install cookies or access non-sensitive information on your device in order to facilitate the reproduction of content, provide features on social networks, create profiles and compile statistics on traffic and usability in our website. You can get MORE INFORMATION by accessing our COOKIES POLICY. I agree More information
Privacy & Cookies Policy
Necessary Always Enabled

Subscribe to our mailing list
Want to be the first to know everything that goes on at the biggest biomedical research hub in Southern Europe? Subscribe to the el·lipse newsletter!

We will send you an email with the latest news.

See you soon!

*Required field

Field is not valid
You have to authorize data treatment

At any time, you can exercise the rights of access, rectification, opposition, portability, limitation to treatment and deletion of the data subject to treatment by clicking on the links "Update data" and "Unsubscribe", sending a letter indicating the right exercised to the postal address indicated at the bottom or to the following email address ellipse@prbb.org